4-Pyridinamine, N-(1-ethylpropyl)-3,6-dimethyl-2-(2,4,6-trimethylphenoxy)-
| Title | Journal |
|---|---|
| Dissociation of corticotropin-releasing factor receptor subtype involvement in sensitivity to locomotor effects of methamphetamine and cocaine. | Psychopharmacology 20120201 |
| Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. | The Journal of neuroscience : the official journal of the Society for Neuroscience 20110803 |
| Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist. | Journal of medicinal chemistry 20110623 |
| Elevated corticosterone in the amygdala leads to persistent increases in anxiety-like behavior and pain sensitivity. | Behavioural brain research 20101225 |
| A comparison of ligand based virtual screening methods and application to corticotropin releasing factor 1 receptor. | Journal of molecular graphics & modelling 20090101 |
| 2-aryloxy-4-alkylaminopyridines: discovery of novel corticotropin-releasing factor 1 antagonists. | Journal of medicinal chemistry 20080313 |